Publication | Open Access
Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis
46
Citations
24
References
2023
Year
Based on changes in L-PF questionnaire scores, nintedanib reduced worsening of dyspnoea, fatigue and cough and the impacts of ILD over 52 weeks in patients with PPF.
| Year | Citations | |
|---|---|---|
Page 1
Page 1